The NLRP3 Inflammasome is a Therapeutic Target for Precision Medicine in Chronic Inflammatory Diseases: Fibrosis to Cancer
Time: 3:00 pm
day: Day 2 - Track B - Afternoon
Details:
- An NME drug homolog of the NLRP3 regulator
- Chronic inflammatory disease platform
- Therapeutic relevance in cancer
